Meningococcal vax market to reach $3.8B by 2019; Gates funds $1.4B vaccine cooler grant;

> The market for meningococcal vaccines should reach $3.76 billion globally in 2019, a new report says. Release

> The Bill & Melinda Gates Foundation has granted $1.4 billion to The Sure Chill Company, which is developing a vaccine cooler that can go without power for more than 35 days. More

> Vaxart has appointed John Harland as its CFO. Release

> New follow-up data from Novavax ($NVAX) suggest its RSV vaccine may warrant annual boosts. More

> African governments have pledged $700 million to fund vaccine purchase between 2016 and 2020. Report

And Finally... The Federal Circuit last week refused to take up a woman's case against the U.S. Department of Health and Human Services claiming her son's autism was caused by vaccines. More (sub. req.)

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.